Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allen R Chauvenet

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The Journal of Supportive Oncology|March 31, 2005
Optimizing care with rasburicaseJulia M Cruz, Allen R Chauvenet
SAGE Open Medicine|January 16, 2016
Hereditary spherocytosis: Consequences of delayed diagnosisSarah C Steward, Allen R Chauvenet, Chibuzo O'Suoji
Pediatric Blood & Cancer|November 1, 2013
Repeating blood cultures in neutropenic children with persistent fevers when the initial blood culture is negativeMatthew W Thomas, Allen R Chauvenet, Chibuzo O'Suoji
The West Virginia Medical Journal|February 4, 2015
Nasopharyngeal rhabdomyosarcoma mimicking a peritonsillar abscessSarah C Steward, Allen R Chauvenet, Chibuzo O'Suoji
Pediatrics|October 4, 2005
Recent steroid therapy increases severity of varicella infections in children with acute lymphoblastic leukemiaGarick Hill, Allen R Chauvenet, James Lovato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2005
Central venous lines in children with lesser risk acute lymphoblastic leukemia: optimal type and timing of placementThomas W McLean, Christen J Fisher, Beverly M Snively, et al.
Journal of Pediatric Hematology/Oncology|April 8, 2003
Vincristine-induced neuropathy as the initial presentation of charcot-marie-tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group studyAllen R Chauvenet, Vandana Shashi, Clifford Selsky, et al.
Journal of Pediatric Hematology/Oncology|February 7, 2003
Religiosity is associated with the use of complementary medical therapies by pediatric oncology patientsElizabeth A McCurdy, John G Spangler, Marcia M Wofford, et al.
Journal of Pediatric Hematology/Oncology|March 18, 2014
In replyPatricia K Duffner, Floyd Daniel Armstrong, Kathleen Helton, et al.
Pediatric Blood & Cancer|October 4, 2005
APE chemotherapy for children with relapsed Hodgkin disease: a Pediatric Oncology Group trialRobert S Wimmer, Allen R Chauvenet, Wendy B London, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The Journal of Supportive Oncology|March 31, 2005
Optimizing care with rasburicaseJulia M Cruz, Allen R Chauvenet
SAGE Open Medicine|January 16, 2016
Hereditary spherocytosis: Consequences of delayed diagnosisSarah C Steward, Allen R Chauvenet, Chibuzo O'Suoji
Pediatric Blood & Cancer|November 1, 2013
Repeating blood cultures in neutropenic children with persistent fevers when the initial blood culture is negativeMatthew W Thomas, Allen R Chauvenet, Chibuzo O'Suoji
The West Virginia Medical Journal|February 4, 2015
Nasopharyngeal rhabdomyosarcoma mimicking a peritonsillar abscessSarah C Steward, Allen R Chauvenet, Chibuzo O'Suoji
Pediatrics|October 4, 2005
Recent steroid therapy increases severity of varicella infections in children with acute lymphoblastic leukemiaGarick Hill, Allen R Chauvenet, James Lovato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2005
Central venous lines in children with lesser risk acute lymphoblastic leukemia: optimal type and timing of placementThomas W McLean, Christen J Fisher, Beverly M Snively, et al.
Journal of Pediatric Hematology/Oncology|April 8, 2003
Vincristine-induced neuropathy as the initial presentation of charcot-marie-tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group studyAllen R Chauvenet, Vandana Shashi, Clifford Selsky, et al.
Journal of Pediatric Hematology/Oncology|February 7, 2003
Religiosity is associated with the use of complementary medical therapies by pediatric oncology patientsElizabeth A McCurdy, John G Spangler, Marcia M Wofford, et al.
Journal of Pediatric Hematology/Oncology|March 18, 2014
In replyPatricia K Duffner, Floyd Daniel Armstrong, Kathleen Helton, et al.
Pediatric Blood & Cancer|October 4, 2005
APE chemotherapy for children with relapsed Hodgkin disease: a Pediatric Oncology Group trialRobert S Wimmer, Allen R Chauvenet, Wendy B London, et al.
Pageof 2